Pfizer stock is undervalued with strong non-COVID growth, robust Q2 2025 results, and strategic R&D pivots. See more on PFE ...

Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

One of the highest yields you can get right now is from Pfizer (NYSE: PFE). The healthcare giant offers a yield of 6.8%, ...

The stock trades at an exceptionally attractive valuation. Pfizer faces some challenges but should continue to survive and ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...

All of us could use a little more monthly income; it’s not just for retired folks anymore. Considering the state of the economy and the rising household expenses, the idea of receiving a monthly ...

Looking into the current session, Pfizer Inc. (PFE) shares are trading at $25.84, after a 0.39% increase. Moreover, over the ...

Pfizer ($PFE) may finally be turning the corner on its post-pandemic revenue challenges. The company recently reported ...

James Brumley has positions in Coca-Cola. The Motley Fool has positions in and recommends Amazon, Equifax, MercadoLibre, ...

This podcast was recorded on August 20, 2025. Tyler Crowe: The AI market is in a frothy mood again, and there's some big shake ups in retail. This is Motley Fool Money.

I recently discussed this subject with Aidan Metzinger, Senior Director, Pfizer Marketing Excellence & Academy, who agrees: ...

Despite the positive outlook, Pfizer still faces substantive execution risks. The looming challenge of losing exclusivity on certain drugs could impact revenue streams significantly. Moreover, while ...